A carregar...
A New Role for ERα: Silencing via DNA methylation of Basal, Stem Cell, and EMT Genes
Resistance to hormonal therapies is a major clinical problem in the treatment of estrogen receptor-α (ERα) positive breast cancers. Epigenetic marks namely DNA methylation of cytosine at specific CpG sites (5mCpG) are frequently associated with ERα-positive status in human breast cancers. Therefore,...
Na minha lista:
| Publicado no: | Mol Cancer Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5308451/ https://ncbi.nlm.nih.gov/pubmed/28108626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-16-0283 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|